Latest Trends and Opportunities in Global Vaccines Market
According to a new report published by Reports Monitor titled, “Global Vaccines Market, Growth Opportunities, Innovations and Forecast, 2017-2025,”the vaccines market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025.
During last decade technological advancement and increased government expenditure are carried out many vaccines which counter the life threatening diseases which drive the growth of the market. A vaccine contains biological preparation that helps to prevent from specific disease. In February 2017 Indian government launch the Pan-India Measles-Rubella Vaccination to protect children from major childhood diseases.
Furthermore, rising government initiative worldwide to promote the awareness of vaccination benefit through immunization are support the market to expand. New vaccines launch by different players in the market are propels the market growth. Increasing prevalence of infectious disease are helps the market to grow exponentially. Presence of several pipeline drugs and undergoing clinical trial will boost the growth of the market in coming time.
This report provides a detailed analysis of vaccines market, which includes current industry situations such as market size, growth and demands, market outlook, major players with their key strategies such as investment, mergers and acquisitions, value chain analysis and swot analysis. It covers the market canvas and the growth opportunities in the coming years. The report has been made with an in-depth analysis along with important inputs from the various industry experts. The research is carried out with both extensive primary and secondary data sources with bottom-up and top-down approaches.
Segmentation of vaccine market is majorly focuses on type, application and distribution channel. Based on type the market is segmented into subunit vaccines, conjugate vaccines, inactivated vaccines, dna vaccines, attenuated vaccines, toxoid vaccines and others. While based on application the market is segmented into infectious diseases, cancer, autism, allergy and others. On the basis of end user, the market is segmented into hospital pharmacies and retail pharmacies.
Global Vaccines market is majorly analyzed across: North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). Developed healthcare infrastructure, higher government expenditure on healthcare and presence of major vaccines manufacturing companies are driving the growth of the market in North America. Growing population & disposal income, government initiative in launching different programme to supply vaccines for basic life threatening disease, rising prevalence of infectious disease and higher penetration of private player in the developing countries such as china and India are contributing the growth of the vaccine market in Asia-Pacific market.
Major vendors operating in the global vaccines market are: Pfizer Inc., Merck & Co. Inc., Serum Institute of India Ltd, GlaxoSmithKline plc. Sanofi Pasteur SA, Emergent BioSolutions Inc., CSL Ltd, Janssen Pharmaceutical Company, Novavax AB and Mitsubishi Tanabe Pharma Corporation.
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.